Publicaciones
- 
                        Aschero MR, Simao M, Català-Mora J and Chantada G. Risk Factors for Extraocular Relapse in Retinoblastoma.SEMINARS IN OPHTHALMOLOGY . 40(6): 474-484. 
- 
                        Balaguer-Lluna L, Gene-Olaciregui N, Aschero MR, Resa-Parés C, Paco-Mercader S, Cuadrado-Vilanova M, Burgeño-Sandoval V, Baulenas-Farrés M, Monterrubio C, Manzanares-Quintela A, Rodriguez E, Lavarino C, Mora J and Carcaboso AM. Establishment of xenografts and methods to evaluate tumor burden for the three most frequent subclasses of pediatric-type diffuse high grade gliomasJOURNAL OF NEURO-ONCOLOGY . 172(3): 599-611. Nº de citas: 2 
- 
                        Baulenas-Farrés M, Paco-Mercader S, Marino F, Mohr J, Panisello C, Balaguer-Lluna L, Aschero MR, Cuadrado-Vilanova M, Resa-Parés C, Rodriguez E, Márquez-Pereira JM, Menéndez P, Jou-Munoz C, Benítez R, Benitez-Ribas D, Lavarino C, Mora J and Carcaboso AM. Proteins of the cancer cell secretome induce the protumoral microenvironment of diffuse intrinsic pontine gliomaneuro-oncology advances . 7(1): . 
- 
                        Cancela MB, Winter U, Zugbi S, Dinardi M, Alves da Quinta D, Aschero MR, Ganiewich D, Sampor C, Sgroi M, Lagomarsino E, Fandiño A, Llera AS, Chantada G, Carcaboso AM and Schaiquevich P. Mimicking Retinoblastoma Treatment With Repeated Topotecan or Melphalan Develops Cross-Resistance to Classic Agents But Not to Repurposed DrugsINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE . 65(14): 14-14. Nº de citas: 1 
- 
                        Panisello, C, Aschero MR, Martinez-Moreno, A, Ho, HR, Falgas, A, González-Navarro, EA, Carabelli, J, Pradenas, E, Lázaro-Díez, M, Prado, JG, Blanco, J, Carrillo, J, Juan-Otero M, Carcaboso AM, Bueno, C and Menendez, P. NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid-lymphoid representation with limited graft-versus-host diseaseJournal for ImmunoTherapy of Cancer . 12(10): . Nº de citas: 2 
- 
                        Cancela MB, Dinardi M, Aschero MR, Zugbi S, Chantada G, Baroni L and Schaiquevich P. The importance of basic and translational research in caring for children with malignant solid tumors in Latin AmericaREVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH . 48: . Nº de citas: 3 
- 
                        Aschero MR, Ganiewich D, Lamas G, Restrepo-Perdomo CA, Ottaviani D, Zugbi S, Camarero S, Néspoli E, Cuadrado-Vilanova M, Pérez-Jaume S, Pascual-Pastó G, Sampor C, Grigorovski N, Salas B, Suñol M, Carcaboso AM, Mora J, de Dávila MTG, Doz F, Radvanyi F, Abramson DH, Llera AS, Schaiquevich PS, Lubieniecki F and Chantada G. Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastomaPEDIATRIC BLOOD & CANCER . 71(1): . Nº de citas: 5 
- 
                        Aschero MR, Castillo H, Baulenas-Farrés M, Resa-Parés C, Jiménez-Cabaco A, Rodriguez E, Monterrubio C, Pérez-Jaume S, Suñol M, Chantada G, Lavarino C, Mora J and Carcaboso AM. Prognostic value of xenograft engraftment in patients with metastatic high-risk neuroblastomaPEDIATRIC BLOOD & CANCER . 70(6): . Nº de citas: 4 
- 
                        Pascual-Pastó G, Resa-Parés C, Castillo H, Aschero MR, Baulenas-Farrés M, Vilà-Ubach M, Burgeño-Sandoval V, Balaguer-Lluna L, Cuadrado-Vilanova M, Gene-Olaciregui N, Martinez N, Pérez-Jaume S, de Alava, E, Tirado, OM, Lavarino C, Mora J and Carcaboso AM. Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcomaBIOCHEMICAL PHARMACOLOGY . 208: 115408-115408. Nº de citas: 8 
- 
                        Cuadrado-Vilanova M, Burgeño-Sandoval V, Balaguer-Lluna L, Aschero MR, Castillo H, Liu, J, Pérez-Jaume S, Pascual-Pastó G, Gene-Olaciregui N, Gomez-Gonzalez S, Correa, G, Suñol M, Schaiquevich, P, Radvanyi, F, Lavarino C, Mora J, Català-Mora J, Chantada G and Carcaboso AM. Follow-up of intraocular retinoblastoma through the quantitative analysis of conserved nuclear DNA sequences in aqueous humor from patientsJOURNAL OF PATHOLOGY CLINICAL RESEARCH . 9(1): 32-43. Nº de citas: 3 
